One of the Nigeria’s finest manufacturing and Distribution company which operates in the pharma space and also produce Consumer goods has announced a massive improvement in its financial operations for the first 6months of 2018. Its reported profit after tax for the period under review grew 533% from N95million reported the previous same period to arrive at N601Million for the half year ended 30th June, 2018.
The company’s revenue for the period under review also grew marginally by 3.21% from N4.4 billion to N4.6 billion in the corresponding period
The shareholders’ earnings per share advanced by 533% also to hit 61kobo away from the 10kobo recorded in the last same period of 2017.
The current period’s PE Ratio is at 3.99x with an earnings yield of 25% at an equity price of N2.45 per unit as at the date of computation.